KLTO קצב צמיחת רווח למניה בשנה הנוכחית anewmeds.com

Klotho Neurosciences Inc (KLTO) is implementing AI protein modeling to accelerate the discovery of dementia drugs while researching the anti-aging properties of the Klotho protein. The annual EPS growth rate reflects the result of this synergy, with the value recorded at 0.00. A stable staff of Alzheimer's and Parkinson's disease experts provides the foundation for the successful launch of new clinical trials.

Klotho Neurosciences Inc (KLTO) specializes in developing innovative treatments for age-related and neurodegenerative pathologies. The eps_yy_co metric measures the year-over-year dynamics of earnings per share, reflecting the efficiency of capital management. For companies in the preclinical research stage, this indicator reveals the impact of investment inflows on financial results. A positive trend signals an increase in the asset's fundamental value. By analyzing the rate of change in earnings per share over 12 months, an investor can assess the business's competitiveness.